Search Results

There are 21107 results for: content related to: Which patients benefit from hemodialysis therapy in hepatorenal syndrome?

  1. Is Continuous Venovenous Hemofiltration Effective Against Severe Acute Pancreatitis?

    Artificial Organs

    Volume 37, Issue 7, July 2013, Pages: 615–622, Shiqi Wang, Lei Xu, Xiangying Feng, Shujun Li, Quanxin Feng, Chaoxu Liu, Xujie Zhang and Qingchuan Zhao

    Version of Record online : 5 MAR 2013, DOI: 10.1111/aor.12051

  2. Regional Citrate Anticoagulation Reduces Polymorphonuclear Cell Degranulation in Critically Ill Patients Treated With Continuous Venovenous Hemofiltration

    Therapeutic Apheresis and Dialysis

    Volume 15, Issue 6, December 2011, Pages: 556–564, Khajohn Tiranathanagul, Onanong Jearnsujitwimol, Paweena Susantitaphong, Narin Kijkriengkraikul, Asada Leelahavanichkul, Nattachai Srisawat, Kearkiat Praditpornsilpa and Somchai Eiam-Ong

    Version of Record online : 23 NOV 2011, DOI: 10.1111/j.1744-9987.2011.00996.x

  3. Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD)

    Hemodialysis International

    Volume 18, Issue 3, July 2014, Pages: 641–649, Rolando Claure-Del Granado, Etienne Macedo, Sharon Soroko, YeonWon Kim, Glenn M. Chertow, Jonathan Himmelfarb, T. Alp Ikizler, Emil P. Paganini and Ravindra L. Mehta

    Version of Record online : 12 MAR 2014, DOI: 10.1111/hdi.12157

  4. Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy

    Nursing in Critical Care

    Volume 14, Issue 4, July and August 2009, Pages: 191–199, Joanne Tillman

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1478-5153.2009.00339.x

  5. Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations


    Volume 11, Issue 5, October 2006, Pages: 405–409, SANDEEP MUNJAL and A AHSAN EJAZ

    Version of Record online : 29 SEP 2006, DOI: 10.1111/j.1440-1797.2006.00653.x

  6. Measurement and Calculation of the Extracorporeal Elimination of Vancomycin During Continuous Venovenous Hemodiafiltration and Continuous Venovenous Hemofiltration in Critically Ill Patients

    Journal of Intensive Care Medicine

    Volume 16, Issue 5, September/October 2001, Pages: 222–230, Elke Muhl, Jens Bundesen, Heiko Iven and Hans-Peter Bruch

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1525-1489.2001.00222.pp.x

  7. Continuous Renal Replacement Therapy: Cause and Treatment of Electrolyte Complications

    Seminars in Dialysis

    Volume 23, Issue 6, November/December 2010, Pages: 581–585, Pamela Fall and Harold M. Szerlip

    Version of Record online : 20 DEC 2010, DOI: 10.1111/j.1525-139X.2010.00790.x

  8. Pharmakokinetik und Dosierung von Fluconazol bei kontinuierlichen Hämofiltrations- (CAVH, CVVH) und Hämodialyseverfahren (CAVHD, CVVHD)


    Volume 41, Issue s2, October 1998, Pages: 86–88, L. Pittrow and A. Penk

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1439-0507.1998.tb00610.x

  9. Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy

    Acta Anaesthesiologica Scandinavica

    Volume 56, Issue 2, Febuary 2012, Pages: 147–157, S. VAARA, V. PETTILA and K.-M. KAUKONEN

    Version of Record online : 19 OCT 2011, DOI: 10.1111/j.1399-6576.2011.02571.x

  10. Adequacy Indices for Dialysis in Acute Renal Failure: Kinetic Modeling

    Artificial Organs

    Volume 34, Issue 5, May 2010, Pages: 412–419, Malgorzata Debowska, Bengt Lindholm and Jacek Waniewski

    Version of Record online : 5 MAY 2010, DOI: 10.1111/j.1525-1594.2009.00873.x

  11. The impact of long-term haemofiltration (continuous veno-venous haemofiltration) on cell-mediated immunity during endotoxaemia

    Acta Anaesthesiologica Scandinavica

    Volume 51, Issue 6, July 2007, Pages: 679–686, P. Toft, 1 B. U. Nilsen, 1 P. Bollen, 2 S. Lillevang, 3 K. E. Olsen, 4 A. C. Brøchner and 3 N. H. Larsen 1

    Version of Record online : 12 JUN 2007, DOI: 10.1111/j.1399-6576.2007.01312.x

  12. Enhanced elimination of dabigatran: Identifying the appropriate patient for the use of continuous venovenous hemodialysis instead of intermittent hemodialysis—A simulation analysis

    The Journal of Clinical Pharmacology

    Volume 56, Issue 5, May 2016, Pages: 597–608, Karl-Heinz Liesenfeld, Fredrik Gruenenfelder and Andreas Clemens

    Version of Record online : 5 NOV 2015, DOI: 10.1002/jcph.620

  13. Extracorporeal circuit pressure profiles during continuous venovenous haemofiltration

    Nursing in Critical Care

    Volume 12, Issue 2, March and April 2007, Pages: 81–85, A Ahsan Ejaz, Ron M Komorski, Glyn H Ellis and Sandeep Munjal

    Version of Record online : 21 MAR 2007, DOI: 10.1111/j.1478-5153.2006.00192.x

  14. Use of an In Vitro Model of Renal Replacement Therapy Systems to Estimate Extracorporeal Drug Removal

    The Journal of Clinical Pharmacology

    Volume 52, Issue S1, January 2012, Pages: 35S–44S, Mariann D. Churchwell

    Version of Record online : 23 APR 2013, DOI: 10.1177/0091270011415979

  15. Severe carbamazepine intoxication unresponsive to albumin-enhanced continuous venovenous hemodiafiltration with low dialysate flow

    Hemodialysis International

    Volume 18, Issue 2, April 2014, Pages: 551–555, Young K. Chung, Kyung Y. Chang, Hoon S. Park, Mi-Hee Kim, Kang-Min Lee, Tae-Seok Lim and Hyung W. Kim

    Version of Record online : 15 JAN 2014, DOI: 10.1111/hdi.12132

  16. Clearance of myoglobin by high cutoff continuous veno-venous hemodialysis in a patient with rhabdomyolysis: A case report

    Hemodialysis International

    Volume 19, Issue 1, January 2015, Pages: 135–140, Buyun Wu, Dehua Gong, Daxi Ji, Bin Xu and Zhihong Liu

    Version of Record online : 27 APR 2014, DOI: 10.1111/hdi.12172

  17. You have free access to this content
    Impact of Different Types of Resuscitation Fluids on Coagulation and Continuous Venovenous Hemofiltration Hemocompatibility in a Porcine Model

    Therapeutic Apheresis and Dialysis

    Volume 17, Issue 5, October 2013, Pages: 510–523, Janis Rebecca Bedarf, Sascha Grosch-Ott, Martin Russ, Johanna Josophina Wagner, Bernhard Hiebl, Michael Kirschfink and Juliane Katharina Unger

    Version of Record online : 1 MAR 2013, DOI: 10.1111/1744-9987.12014

  18. Pharmacokinetics of Levofloxacin During Continuous Venovenous Hemodiafiltration and Continuous Venovenous Hemofiltration in Critically Ill Patients

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 2, February 2002, Pages: 175–183, Mr. Sven G. Guenter, Dr. Heiko Iven, Dr. Carsten Boos, Dr. Hans-Peter Bruch and Dr. Elke Muhl

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.

  19. The Effect of Continuous Veno-Venous Hemofiltration or Direct Hemoperfusion With Polymyxin B-Immobilized Fiber on Neutrophil Respiratory Oxidative Burst in Patients With Sepsis and Septic Shock

    Therapeutic Apheresis and Dialysis

    Volume 10, Issue 1, February 2006, Pages: 7–11, Toshio Naka, Masahiro Shinozaki, Tadao Akizawa, Yukihiro Shima, Hideki Takaesu and Hideki Nasu

    Version of Record online : 20 MAR 2006, DOI: 10.1111/j.1744-9987.2006.00339.x

  20. Evaluation of Plasma Exchange and Continuous Veno-Venous Hemofiltration for the Treatment of Severe Avian Influenza A (H7N9): A Cohort Study

    Therapeutic Apheresis and Dialysis

    Volume 19, Issue 2, April 2015, Pages: 178–184, Xiaoli Liu, Yimin Zhang, Xiaowei Xu, Weibo Du, Kunkai Su, Chunxia Zhu, Yuemei Chen, Shuiying Lei, Shufa Zheng, Jianwen Jiang, Shigui Yang, Jing Guo, Li Shao, Qian Yang, Jiajia Chen and Lanjuan Li

    Version of Record online : 3 NOV 2014, DOI: 10.1111/1744-9987.12240